Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76660863 | 7666086 | 3 | F | 20081230 | 20160831 | 20101112 | 20160831 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-15371750 | BRISTOL MYERS SQUIBB | 0.00 | DY | M | Y | 2.02000 | KG | 20160831 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76660863 | 7666086 | 1 | PS | ORENCIA | ABATACEPT | 1 | Transplacental | 1 DF, QMO | U | 125118 | 1 | DF | SOLUTION FOR INFUSION | /month | |||||
| 76660863 | 7666086 | 2 | SS | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | Transplacental | GASTRO-RESISTANT AND FILM-COATED TABLET | U | 0 | 360 | MG | |||||||
| 76660863 | 7666086 | 3 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Transplacental | UNK UNK, QD | U | 0 | QD | ||||||||
| 76660863 | 7666086 | 4 | SS | APRANAX | NAPROXEN | 1 | Transplacental | UNK UNK, QD | U | 0 | QD | ||||||||
| 76660863 | 7666086 | 5 | SS | CORTANCYL | PREDNISONE | 1 | Transplacental | 10 MG, UNK | U | 0 | 10 | MG | |||||||
| 76660863 | 7666086 | 6 | SS | COLCHICINE. | COLCHICINE | 1 | Transplacental | 1 MG, QD | U | 0 | 1 | MG | QD | ||||||
| 76660863 | 7666086 | 7 | SS | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Transplacental | 500 MG, QD | U | 0 | 500 | MG | QD | ||||||
| 76660863 | 7666086 | 8 | SS | SPECIAFOLDINE | FOLIC ACID | 1 | Transplacental | 5 MG, UNK | U | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 76660863 | 7666086 | 1 | Product used for unknown indication |
| 76660863 | 7666086 | 2 | Product used for unknown indication |
| 76660863 | 7666086 | 3 | Product used for unknown indication |
| 76660863 | 7666086 | 4 | Product used for unknown indication |
| 76660863 | 7666086 | 5 | Product used for unknown indication |
| 76660863 | 7666086 | 6 | Product used for unknown indication |
| 76660863 | 7666086 | 7 | Product used for unknown indication |
| 76660863 | 7666086 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 76660863 | 7666086 | OT |
| 76660863 | 7666086 | CA |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 76660863 | 7666086 | Congenital central nervous system anomaly | |
| 76660863 | 7666086 | Foetal exposure during pregnancy | |
| 76660863 | 7666086 | Meningocele | |
| 76660863 | 7666086 | Nervous system disorder | |
| 76660863 | 7666086 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |